New Member: Welcome in our cluster to LBBW Venture Capital
- Dec 1, 2021
- 1 min
Overview on milestones BioRN achieved in 25 years of cluster innovation management
- Nov 30, 2021
- 2 min
Sanofi unterstützt BioLabs-Inkubator in Heidelberg
- Nov 27, 2021
- 2 min
Celebrating Lithuania-EMBL cooperation on life science research
- Nov 27, 2021
- 2 min
3D Bioprinting - Will the gap in treatment options for tendon and joint injuries be closed?
- Nov 22, 2021
- 2 min
Der Gesundheit einen Schritt voraus – 25 Jahre BioRN
- Nov 22, 2021
- 1 min
New Member: Welcome in our cluster to 10x Genomics
- Nov 21, 2021
- 2 min
Owkin becomes ’unicorn’ with $180m investment from Sanofi and four new collaborative projects
- Nov 16, 2021
- 3 min
Using T cells to target malignant brain tumors
- Nov 13, 2021
- 3 min
How Cells Correctly Choose Active Genes
- Nov 13, 2021
- 2 min
Tumor organoids can help overcome therapy resistance of colorectal cancer
- Nov 4, 2021
- 3 min
Structure of a promiscuous protein will help scientists design better drugs
- Nov 4, 2021
- 2 min
Affimed Announces New Innate Cell Engager AFM28 Targeting CD123 to Treat Acute Myeloid Leukemia
- Nov 4, 2021
- 3 min
Strengthening the Heidelberg-Mainz Axis towards faster biomedical innovation
- Nov 3, 2021
- 2 min
BioMed X Institute successfully completes fourth project in oncology in collaboration with Merck